Mehrdad Mobasher, MD, MPH
Mehrdad Mobasher, MD, MPH, joined the business in August 2022 as Chief Medical Officer for Hematology. Before joining BeiGene, Dr. Mobasher was Senior Vice President and Global Head of Late-Stage Cancer Development at Zai Lab, where he was in charge of all of the company's late-stage oncology projects.
Zanubrutinib Outperforms Ibrutinib in Treating Relapsed/Refractory CLL/SLL Dr. Mobasher - Synopsis below extracted from the video transcript.
Read More
